WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • WJPPS: MARCH ISSUE PUBLISHED
  • March Issue has been successfully launched on 1 March 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

Abstract

ROLE OF BALUKASVEDA AND VAITARANA BASTI IN THE MANAGEMENT OF AMAVATA (RHEUMATOID ARTHRITIS)

Akhilanath Parida*, Satyasmita Jena and Varun Sawant

 

ABSTRACT

Amavata is a commonest disorder seen in middle age people which affects both the sex, characterized by angamarda (body pain), aruchi (loss of taste), trishna (thirst), alasya (lack of enthusiasm), gaurava (heaviness), klama (tiredness without doing work), apaka (indigestion) and fever. In the later stage pain may begin to migrate from place to place with a vrishchikadamshavatvedana (intense stinging type of pain) and burning sensation. similar clinical symptoms seen in the disease Rheumatoid Arthritis in modern science. The Treatment principle includes the pain management and steroids in the Allopathic medicine. In Ayurveda according to our classics langhana (light diet or fasting), deepana-pachana (appetizers, digestives and carminatives), samshodhana (different purifications) are suggested. the aim of this study was to evaluate the efficacy of valuka-sweda and vaitaranabasti in the management of amavata. In the present clinical trial 30 patients suffering with amavata were selected and divided into two groups with 15 patients each administered with valuka-sweda and vaitaranabasti. Statistical analysis showed better result in relieving the sign and symptoms of amavata (rheumatoid arthritis) in both the groups. By comparison group b (valukasweda and vaitaranabasti) showed better result than valukasweda alone (group a).

Keywords: Amavata, rheumatoid arthritis, valukasweda, vaitaranabasti.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More